TREMFYA (Guselkumab)

**Product type:** Human Prescription Drug

**Active ingredient:** GUSELKUMAB

**Strength:** 200 mg/20mL

**Dosage form:** Injection

**Route:** Intravenous

**Labeler:** Janssen Biotech, Inc.

**Marketing category:** BLA (BLA761061)

**Pharmacologic class:** Interleukin-23 Antagonist [EPC], Interleukin-23 Antagonists [MoA]